IBALX
Price
$35.08
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
RAMHX
Price
$34.62
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

IBALX vs RAMHX

Header iconIBALX vs RAMHX Comparison
Open Charts IBALX vs RAMHXBanner chart's image
Transamerica Multi-Managed Balanced A
Price$35.08
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$34.62
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IBALX vs RAMHX Comparison Chart
Loading...
VS
IBALX vs. RAMHX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBALX is a StrongBuy and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 234B vs. IBALX (1.33B). RAMHX pays higher dividends than IBALX: RAMHX (1.84) vs IBALX (1.43). IBALX was incepted earlier than RAMHX: IBALX (30 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. IBALX (33.00). RAMHX has a lower initial minimum investment than IBALX: RAMHX (250) vs IBALX (1000). RAMHX annual gain was more profitable for investors over the last year : 19.48 vs. IBALX (16.94). RAMHX return over 5 years is better than : 35.40 vs. IBALX (31.52).
IBALXRAMHXIBALX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years10 years-
Gain YTD13.53012.579108%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B234B1%
Annual Yield % from dividends1.431.8478%
Returns for 1 year16.9419.4887%
Returns for 3 years4.4511.2140%
Returns for 5 years31.5235.4089%
Returns for 10 years49.1648.18102%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRNX53.802.57
+5.02%
Crinetics Pharmaceuticals
DOLE16.160.27
+1.70%
Dole plc
AEON0.74N/A
+0.51%
AEON Biopharma
PKE13.550.03
+0.22%
Park Aerospace Corp
VRSK268.79-0.19
-0.07%
Verisk Analytics